Veterinary Services Market CAGR 8.1% to 2033

The Veterinary Services Market was valued at $156.3B in 2025 and is projected to reach $291.4B by 2033, expanding at an 8.1% CAGR. Growth is concentrated in companion animal care, where the Companion Animal Veterinary Services Market accounts for 62% of global revenue. Pet humanization, preventive medicine, and clinic consolidation are the primary demand multipliers.

• North America holds 38% share, followed by Europe at 27% and Asia-Pacific at 22%.
• Veterinary Medical Services Market represents 58% of service revenue; non-medical services contribute 42%.
• Pet Care Services Market and Pet Insurance Market are adjacent segments growing at 9.4% and 11.2% respectively.

• Companion animal spending rose 6.8% in 2025, outpacing GDP growth in most developed markets.
• Corporate consolidators now control approximately 35% of US veterinary clinics, up from 25% in 2020.
• The Veterinary Telemedicine Market expanded 18% year over year as remote triage became standard.

The Production Animal Veterinary Services Market remains essential for food security, contributing 38% of total revenue. Margin pressure from a 15% veterinarian vacancy rate in the US and 12% in the UK will push further automation and task-shifting to technicians. Investment activity is strongest in emergency care, diagnostics, and pet insurance, where $8.4B in private equity capital was deployed between 2023 and 2025.

Companion animals generate $96.9B of the $156.3B global market. Dogs represent 48% of companion revenue, cats 22%, horses 6%, and other species 24%. The Companion Animal Veterinary Services Market is characterized by high visit frequency, premium diagnostics, and rising surgical intervention rates.

• Dogs: annual wellness visits average 2.3 per pet; dental procedures grew 11% in 2025.
• Cats: visit frequency is 40% lower than dogs, creating an untapped preventive care opportunity.
• Horses: equine specialty practices report 14% higher revenue per patient than companion animal general practice.

The Veterinary Medical Services Market accounts for 58% of service revenue, with in-vitro diagnosis and surgery as the fastest-growing sub-segments. Preventative care is expanding at 9.1% CAGR as pet owners adopt annual bloodwork and vaccines. The Veterinary Non-Medical Services Market covers pet services and livestock services; the Pet Care Services Market alone is valued at $18.2B in 2025.

The Production Animal Veterinary Services Market generates $59.4B globally, led by cattle, poultry, and swine. Cattle represent 42% of production animal revenue, poultry 28%, swine 18%, and others 12%. Herd health programs, vaccination protocols, and regulatory compliance drive recurring demand.

• Labor costs consume 45-55% of operating expenses at consolidated clinics.
• Diagnostic reagent and pharmaceutical input inflation runs at 4-6% annually.
• Debt servicing costs for PE-backed roll-ups increased 200-300 basis points after 2023 rate hikes.

• Global pet spending reached $320B in 2025, with veterinary services capturing 49% of that total.
• The Animal Health Diagnostics Market grew 9.6% in 2025, enabling earlier disease detection and higher treatment revenue.
• Veterinary Pharmaceuticals Market sales rose 5.4%, supported by parasiticides and vaccines.
• Pet Insurance Market penetration reached 4.2% in the US and 12.8% in the UK, funding more elective procedures.

• The US faces a shortage of 15,000 veterinarians, with vacancy rates near 15% in clinical roles.
• Veterinary Diagnostics Reagents Market supply remains concentrated among three global manufacturers, creating 4-8 week backorder risk.
• Cross-border licensing delays add 2-5 days to pharmaceutical distribution in the EU and UK.
• Antitrust reviews in the US, UK, and Australia have slowed clinic acquisitions by 10-15% since 2023.

• IVC Evidensia: operates over 2,500 clinics across 20 countries; private equity backing supports continued tuck-in acquisitions.
• Mars Veterinary Health: owns Banfield, VCA, BluePearl, and Linnaeus; controls more than 3,000 clinics globally.
• CVS Group Plc: UK-listed operator with over 500 practices; active acquirer in Australia and the Netherlands.
• National Veterinary Associates: manages more than 1,000 locations; strong in emergency and specialty care.
• Pets at Home Group PLC: integrates retail and veterinary services across 450+ UK practices.
• Greencross Vets: operates 250+ clinics in Australia; bundled pet care and insurance model.
• Fetch! Pet Care: franchise network for dog walking, boarding, and in-home care; benefits from the Pet Care Services Market.
• A Place for Rover, Inc.: marketplace for pet sitting and dog walking; expands non-medical service access.

• 2023: National Veterinary Associates partnered with Vetster to offer virtual urgent care, reducing emergency room diversion by 12% in pilot clinics.
• 2024: IVC Evidensia completed 120 new clinic openings, increasing its European footprint by 8%.
• 2024: CVS Group Plc acquired 40 UK practices, raising its total to over 500 locations.
• 2025: Mars Veterinary Health acquired a European specialty network, strengthening referral and emergency care capabilities.
• 2025: Greencross Vets launched a pet insurance bundle, targeting 15% attachment rate across its 250+ clinics.

• Asia-Pacific is the fastest-growing region at 10.2% CAGR, led by China, India, and ASEAN. Urbanization and rising disposable income are expanding the Companion Animal Veterinary Services Market.
• North America remains the largest market at $59.4B, but growth is mature at 7.4% CAGR. Consolidation and specialty care drive revenue per clinic.
• Europe grows at 7.9% CAGR, supported by high pet insurance penetration and strict animal welfare rules. The EU CSRD adds ESG reporting costs for large chains.
• South America expands at 7.8% CAGR, with Brazil and Argentina leading production animal services. Livestock export demand supports the Production Animal Veterinary Services Market.
• Middle East & Africa grows at 6.5% CAGR, constrained by fragmented regulation and limited veterinary infrastructure. GCC countries invest in equine and falcon specialty care.

• Private equity firms deployed $8.4B into veterinary services between 2023 and 2025, targeting emergency hospitals and specialty referral centers.
• The Veterinary Diagnostics Reagents Market attracted $620M in venture funding, as point-of-care testing moves into general practice.
• Mars Veterinary Health, IVC Evidensia, and CVS Group Plc accounted for 42% of disclosed clinic acquisitions in 2024.
• The Animal Health Diagnostics Market is a prime target for strategic buyers seeking recurring revenue and higher margins.

• Emergency and specialty care: revenue per visit is 3.5x general practice; PE buyers pay 12-15x EBITDA.
• Veterinary Telemedicine Market: projected 18.5% CAGR through 2033; attracts venture capital and insurer partnerships.
• Pet Insurance Market: premium growth of 11.2% in 2025; insurers bundle policies with clinic networks.
• Veterinary Pharmaceuticals Market: consolidation among distributors creates bargaining power for large clinic chains.

• AI diagnostics: machine learning models for radiographs and cytology reach 92-95% accuracy in validation studies. Adoption will reduce diagnostic turnaround by 30-40% in large hospitals.
• Telemedicine: the Veterinary Telemedicine Market grew 18% in 2025; remote triage lowers emergency visits by 10-15% in pilot programs.
• Point-of-care molecular diagnostics: the Veterinary Diagnostics Reagents Market is shifting toward cartridge-based PCR, with 15-20% annual growth in reagent demand.

• Leading veterinary diagnostic firms invest 6-8% of revenue in R&D, focusing on multiplex panels and AI-assisted imaging.
• Patent filings for veterinary AI diagnostics rose 22% annually between 2021 and 2024.
• Incumbent clinic chains are acquiring diagnostic technology providers to capture in-house testing margins, reinforcing the Animal Health Diagnostics Market.
• The Veterinary Pharmaceuticals Market faces incremental innovation in long-acting injectables and mRNA vaccines for livestock.

• 1. Animal
  • 1.1. Companion Animals
    • 1.1.1. Dogs
    • 1.1.2. Cats
    • 1.1.3. Horses
    • 1.1.4. Others
  • 1.2. Production Animals
    • 1.2.1. Cattle
    • 1.2.2. Poultry
    • 1.2.3. Swine
    • 1.2.4. Others
• 2. Service
  • 2.1. Medical Services
    • 2.1.1. Diagnosis
      • 2.1.1.1. In-Vitro Diagnosis
      • 2.1.1.2. In-Vivo Diagnosis
    • 2.1.2. Preventative Care
    • 2.1.3. Treatment
      • 2.1.3.1. Consultation
      • 2.1.3.2. Surgery
      • 2.1.3.3. Others
  • 2.2. Non-Medical Services
    • 2.2.1. Pet Services
    • 2.2.2. Livestock Services

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific